277 related articles for article (PubMed ID: 22875827)
1. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.
Bossart KN; Rockx B; Feldmann F; Brining D; Scott D; LaCasse R; Geisbert JB; Feng YR; Chan YP; Hickey AC; Broder CC; Feldmann H; Geisbert TW
Sci Transl Med; 2012 Aug; 4(146):146ra107. PubMed ID: 22875827
[TBL] [Abstract][Full Text] [Related]
2. A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge.
Mire CE; Geisbert JB; Agans KN; Feng YR; Fenton KA; Bossart KN; Yan L; Chan YP; Broder CC; Geisbert TW
J Virol; 2014 May; 88(9):4624-31. PubMed ID: 24522928
[TBL] [Abstract][Full Text] [Related]
3. Vaccines to Emerging Viruses: Nipah and Hendra.
Amaya M; Broder CC
Annu Rev Virol; 2020 Sep; 7(1):447-473. PubMed ID: 32991264
[TBL] [Abstract][Full Text] [Related]
4. A treatment for and vaccine against the deadly Hendra and Nipah viruses.
Broder CC; Xu K; Nikolov DB; Zhu Z; Dimitrov DS; Middleton D; Pallister J; Geisbert TW; Bossart KN; Wang LF
Antiviral Res; 2013 Oct; 100(1):8-13. PubMed ID: 23838047
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody.
Geisbert TW; Mire CE; Geisbert JB; Chan YP; Agans KN; Feldmann F; Fenton KA; Zhu Z; Dimitrov DS; Scott DP; Bossart KN; Feldmann H; Broder CC
Sci Transl Med; 2014 Jun; 6(242):242ra82. PubMed ID: 24964990
[TBL] [Abstract][Full Text] [Related]
6. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge.
Yoneda M; Georges-Courbot MC; Ikeda F; Ishii M; Nagata N; Jacquot F; Raoul H; Sato H; Kai C
PLoS One; 2013; 8(3):e58414. PubMed ID: 23516477
[TBL] [Abstract][Full Text] [Related]
7. Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease.
Mire CE; Geisbert JB; Agans KN; Versteeg KM; Deer DJ; Satterfield BA; Fenton KA; Geisbert TW
Emerg Infect Dis; 2019 Jun; 25(6):1144-1152. PubMed ID: 31107231
[TBL] [Abstract][Full Text] [Related]
8. Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection.
Geisbert TW; Daddario-DiCaprio KM; Hickey AC; Smith MA; Chan YP; Wang LF; Mattapallil JJ; Geisbert JB; Bossart KN; Broder CC
PLoS One; 2010 May; 5(5):e10690. PubMed ID: 20502528
[TBL] [Abstract][Full Text] [Related]
9. A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge.
Pallister J; Middleton D; Wang LF; Klein R; Haining J; Robinson R; Yamada M; White J; Payne J; Feng YR; Chan YP; Broder CC
Vaccine; 2011 Aug; 29(34):5623-30. PubMed ID: 21689706
[TBL] [Abstract][Full Text] [Related]
10. Immunization strategies against henipaviruses.
Broder CC; Geisbert TW; Xu K; Nikolov DB; Wang LF; Middleton D; Pallister J; Bossart KN
Curr Top Microbiol Immunol; 2012; 359():197-223. PubMed ID: 22481140
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates.
Zeitlin L; Cross RW; Woolsey C; West BR; Borisevich V; Agans KN; Prasad AN; Deer DJ; Stuart L; McCavitt-Malvido M; Kim DH; Pettitt J; Crowe JE; Whaley KJ; Veesler D; Dimitrov A; Abelson DM; Geisbert TW; Broder CC
Sci Transl Med; 2024 Apr; 16(741):eadl2055. PubMed ID: 38569014
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters.
Lo MK; Spengler JR; Welch SR; Harmon JR; Coleman-McCray JD; Scholte FEM; Shrivastava-Ranjan P; Montgomery JM; Nichol ST; Weissman D; Spiropoulou CF
J Infect Dis; 2020 May; 221(Suppl 4):S493-S498. PubMed ID: 31751453
[TBL] [Abstract][Full Text] [Related]
13. Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice.
Li Y; Li R; Wang M; Liu Y; Yin Y; Zai X; Song X; Chen Y; Xu J; Chen W
Viruses; 2020 Apr; 12(4):. PubMed ID: 32340278
[TBL] [Abstract][Full Text] [Related]
14. Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease.
Prescott J; DeBuysscher BL; Feldmann F; Gardner DJ; Haddock E; Martellaro C; Scott D; Feldmann H
Vaccine; 2015 Jun; 33(24):2823-9. PubMed ID: 25865472
[TBL] [Abstract][Full Text] [Related]
15. Animal challenge models of henipavirus infection and pathogenesis.
Geisbert TW; Feldmann H; Broder CC
Curr Top Microbiol Immunol; 2012; 359():153-77. PubMed ID: 22476556
[TBL] [Abstract][Full Text] [Related]
16. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity.
Prasad AN; Woolsey C; Geisbert JB; Agans KN; Borisevich V; Deer DJ; Mire CE; Cross RW; Fenton KA; Broder CC; Geisbert TW
J Infect Dis; 2020 May; 221(Suppl 4):S436-S447. PubMed ID: 32022850
[TBL] [Abstract][Full Text] [Related]
17. Development of a neutralization assay for Nipah virus using pseudotype particles.
Tamin A; Harcourt BH; Lo MK; Roth JA; Wolf MC; Lee B; Weingartl H; Audonnet JC; Bellini WJ; Rota PA
J Virol Methods; 2009 Sep; 160(1-2):1-6. PubMed ID: 19559943
[TBL] [Abstract][Full Text] [Related]
18. Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine.
Mungall BA; Middleton D; Crameri G; Bingham J; Halpin K; Russell G; Green D; McEachern J; Pritchard LI; Eaton BT; Wang LF; Bossart KN; Broder CC
J Virol; 2006 Dec; 80(24):12293-302. PubMed ID: 17005664
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of Hendra and Nipah virus infection in humans.
Escaffre O; Borisevich V; Rockx B
J Infect Dev Ctries; 2013 Apr; 7(4):308-11. PubMed ID: 23592639
[TBL] [Abstract][Full Text] [Related]
20. Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease.
Monath TP; Nichols R; Feldmann F; Griffin A; Haddock E; Callison J; Meade-White K; Okumura A; Lovaglio J; Hanley PW; Clancy CS; Shaia C; Rida W; Fusco J
Front Immunol; 2023; 14():1216225. PubMed ID: 37731485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
